{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T14:04:20Z","timestamp":1776866660598,"version":"3.51.2"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T00:00:00Z","timestamp":1738972800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T00:00:00Z","timestamp":1738972800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004319","name":"Shin Kong Wu Ho-Su Memorial Hospital","doi-asserted-by":"publisher","award":["2018SKHADR027"],"award-info":[{"award-number":["2018SKHADR027"]}],"id":[{"id":"10.13039\/501100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"DOI":"10.1186\/s13014-025-02585-z","type":"journal-article","created":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T03:12:22Z","timestamp":1738984342000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Phase II clinical trial assessing the addition of hyperthermia to salvage concurrent chemoradiotherapy for unresectable recurrent head and neck cancer in previously irradiated patients"],"prefix":"10.1186","volume":"20","author":[{"given":"Kai-Lin","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mau-Shin","family":"Chi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chung-Yu","family":"Hao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui-Ling","family":"Ko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Ying","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ren-Hong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hung-Chih","family":"Lai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying-Chu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheng-Po","family":"Hao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kwan-Hwa","family":"Chi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,8]]},"reference":[{"issue":"3","key":"2585_CR1","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.ijrobp.2006.12.055","volume":"68","author":"N Lee","year":"2007","unstructured":"Lee N, Chan K, Bekelman JE, Zhung J, Mechalakos J, Narayana A, et al. Salvage re-irradiation for recurrent head and neck cancer. International Journal of Radiation Oncology Biology Physics. 2007;68(3):731\u201340.","journal-title":"International Journal of Radiation Oncology Biology Physics."},{"issue":"24","key":"2585_CR2","doi-asserted-by":"publisher","first-page":"5568","DOI":"10.1200\/JCO.2005.07.119","volume":"23","author":"J Baselga","year":"2005","unstructured":"Baselga J, Trigo JM, Bourhis J, Tortochaux J, Cort\u00e9s-Funes H, Hitt R, et al. Phase II multicenter study of the antiepidermal growth factor receptor monoclonal antibody cetuximab in combination with platinum-based chemotherapy in patients with platinum-refractory metastatic and\/or recurrent squamous cell carcinoma of the head and neck. J Clin Oncol. 2005;23(24):5568\u201377.","journal-title":"J Clin Oncol"},{"issue":"19","key":"2585_CR3","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1056\/NEJMoa1602252","volume":"375","author":"RL Ferris","year":"2016","unstructured":"Ferris RL, Blumenschein G Jr, Fayette J, Guigay J, Colevas AD, Licitra L, et al. Nivolumab for recurrent squamous-cell carcinoma of the head and neck. N Engl J Med. 2016;375(19):1856\u201367.","journal-title":"N Engl J Med"},{"issue":"11","key":"2585_CR4","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1056\/NEJMoa0802656","volume":"359","author":"JB Vermorken","year":"2008","unstructured":"Vermorken JB, Mesia R, Rivera F, Remenar E, Kawecki A, Rottey S, et al. Platinum-based chemotherapy plus cetuximab in head and neck cancer. N Engl J Med. 2008;359(11):1116\u201327.","journal-title":"N Engl J Med"},{"issue":"2","key":"2585_CR5","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.ijrobp.2005.07.005","volume":"64","author":"JK Salama","year":"2006","unstructured":"Salama JK, Vokes EE, Chmura SJ, Milano MT, Kao J, Stenson KM, Witt ME, Haraf DJ. Long-term outcome of concurrent chemotherapy and reirradiation for recurrent and second primary head-and-neck squamous cell carcinoma. International Journal of Radiation Oncology Biology Physics. 2006;64(2):382\u201391.","journal-title":"International Journal of Radiation Oncology Biology Physics."},{"issue":"3","key":"2585_CR6","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.ijrobp.2017.06.012","volume":"100","author":"MC Ward","year":"2018","unstructured":"Ward MC, Riaz N, Caudell JJ, Dunlap NE, Isrow D, Zakem SJ, et al. Refining Patient Selection for Reirradiation of Head and Neck Squamous Carcinoma in the IMRT Era: A Multi-institution Cohort Study by the MIRI Collaborative. Int J Radiat Oncol Biol Phys. 2018;100(3):586\u201394.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"2585_CR7","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.clon.2004.10.008","volume":"17","author":"AL Creak","year":"2005","unstructured":"Creak AL, Harrington K, Nutting C. Treatment of recurrent head and neck cancer: re-irradiation or chemotherapy? Clin Oncol (R Coll Radiol). 2005;17(3):138\u201347.","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"4","key":"2585_CR8","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1016\/j.ijrobp.2004.12.062","volume":"62","author":"S Temam","year":"2005","unstructured":"Temam S, Pape E, Janot F, Wibault P, Julieron M, Lusinchi A, et al. Salvage surgery after failure of very accelerated radiotherapy in advanced head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys. 2005;62(4):1078\u201383.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"2585_CR9","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1001\/jama.296.4.445","volume":"296","author":"DS Coffey","year":"2006","unstructured":"Coffey DS, Getzenberg RH, DeWeese TL. Hyperthermic biology and cancer therapies: a hypothesis for the \u201cLance Armstrong effect.\u201d JAMA. 2006;296(4):445\u20138.","journal-title":"JAMA"},{"issue":"1","key":"2585_CR10","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1080\/02656730701769841","volume":"24","author":"JL Roti Roti","year":"2008","unstructured":"Roti Roti JL. Cellular responses to hyperthermia (40\u201346 degrees C): cell killing and molecular events. Int J Hyperthermia. 2008;24(1):3\u201315.","journal-title":"Int J Hyperthermia"},{"issue":"8","key":"2585_CR11","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1080\/02656730500272856","volume":"21","author":"PM Corry","year":"2005","unstructured":"Corry PM, Dewhirst MW. Thermal medicine, heat shock proteins and cancer. Int J Hyperthermia. 2005;21(8):675\u20137.","journal-title":"Int J Hyperthermia"},{"issue":"8949","key":"2585_CR12","first-page":"540","volume":"345","author":"J Overgaard","year":"1995","unstructured":"Overgaard J, Gonzalez Gonzalez D, Hulshof MC, Arcangeli G, Dahl O, Mella O, et al. Randomised trial of hyperthermia as adjuvant to radiotherapy for recurrent or metastatic malignant melanoma. European Society for Hyperthermic Oncology Lancet. 1995;345(8949):540\u20133.","journal-title":"European Society for Hyperthermic Oncology Lancet"},{"issue":"3","key":"2585_CR13","doi-asserted-by":"publisher","first-page":"289","DOI":"10.3109\/02656739209021783","volume":"8","author":"K Sugimachi","year":"1992","unstructured":"Sugimachi K, Kitamura K, Baba K, Ikebe M, Morita M, Matsuda H, et al. Hyperthermia combined with chemotherapy and irradiation for patients with carcinoma of the oesophagus\u2013a prospective randomized trial. Int J Hyperthermia. 1992;8(3):289\u201395.","journal-title":"Int J Hyperthermia"},{"issue":"4","key":"2585_CR14","doi-asserted-by":"publisher","first-page":"485","DOI":"10.3109\/02656739409009352","volume":"10","author":"K Sugimachi","year":"1994","unstructured":"Sugimachi K, Kuwano H, Ide H, Toge T, Saku M, Oshiumi Y. Chemotherapy combined with or without hyperthermia for patients with oesophageal carcinoma: a prospective randomized trial. Int J Hyperthermia. 1994;10(4):485\u201393.","journal-title":"Int J Hyperthermia"},{"issue":"1","key":"2585_CR15","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/0360-3016(94)90154-6","volume":"28","author":"R Valdagni","year":"1994","unstructured":"Valdagni R, Amichetti M. Report of long-term follow-up in a randomized trial comparing radiation therapy and radiation therapy plus hyperthermia to metastatic lymph nodes in stage IV head and neck patients. Int J Radiat Oncol Biol Phys. 1994;28(1):163\u20139.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"9210","key":"2585_CR16","first-page":"1119","volume":"355","author":"J van der Zee","year":"2000","unstructured":"van der Zee J, Gonzalez Gonzalez D, van Rhoon GC, van Dijk JD, van Putten WL, Hart AA. Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: a prospective, randomised, multicentre trial. Dutch Deep Hyperthermia Group Lancet. 2000;355(9210):1119\u201325.","journal-title":"Dutch Deep Hyperthermia Group Lancet"},{"issue":"2","key":"2585_CR17","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/S0360-3016(97)00731-1","volume":"40","author":"PK Sneed","year":"1998","unstructured":"Sneed PK, Stauffer PR, McDermott MW, Diederich CJ, Lamborn KR, Prados MD, et al. Survival benefit of hyperthermia in a prospective randomized trial of brachytherapy boost +\/- hyperthermia for glioblastoma multiforme. Int J Radiat Oncol Biol Phys. 1998;40(2):287\u201395.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"2585_CR18","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/0360-3016(96)00154-X","volume":"35","author":"CC Vernon","year":"1996","unstructured":"Vernon CC, Hand JW, Field SB, Machin D, Whaley JB, van der Zee J, van Putten WL, van Rhoon GC, van Dijk JD, Gonz\u00e1lez DG. Radiotherapy with or without hyperthermia in the treatment of superficial localized breast cancer: results from five randomized controlled trials. International Journal of Radiation Oncology Biology Physics. 1996;35(4):731\u201344.","journal-title":"International Journal of Radiation Oncology Biology Physics."},{"issue":"13","key":"2585_CR19","doi-asserted-by":"publisher","first-page":"3079","DOI":"10.1200\/JCO.2005.05.520","volume":"23","author":"EL Jones","year":"2005","unstructured":"Jones EL, Oleson JR, Prosnitz LR, Samulski TV, Vujaskovic Z, Yu D, et al. Randomized trial of hyperthermia and radiation for superficial tumors. J Clin Oncol. 2005;23(13):3079\u201385.","journal-title":"J Clin Oncol"},{"issue":"1","key":"2585_CR20","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3109\/02656736.2015.1099746","volume":"32","author":"NR Datta","year":"2016","unstructured":"Datta NR, Rogers S, Ordonez SG, Puric E, Bodis S. Hyperthermia and radiotherapy in the management of head and neck cancers: A systematic review and meta-analysis. Int J Hyperthermia. 2016;32(1):31\u201340.","journal-title":"Int J Hyperthermia"},{"issue":"5","key":"2585_CR21","doi-asserted-by":"publisher","first-page":"e639","DOI":"10.1016\/j.ijrobp.2012.02.057","volume":"83","author":"K Mitsudo","year":"2012","unstructured":"Mitsudo K, Koizumi T, Iida M, Iwai T, Oguri S, Yamamoto N, Itoh Y, Kioi M, Hirota M, Tohnai I. Thermochemoradiation therapy using superselective intra-arterial infusion via superficial temporal and occipital arteries for oral cancer with N3 cervical lymph node metastases. International Journal of Radiation Oncology*Biology*Physics. 2012;83(5):e639\u201345. https:\/\/doi.org\/10.1016\/j.ijrobp.2012.02.057.","journal-title":"International Journal of Radiation Oncology*Biology*Physics"},{"issue":"8","key":"2585_CR22","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1002\/1097-0142(19861015)58:8<1589::AID-CNCR2820580802>3.0.CO;2-B","volume":"58","author":"M Abe","year":"1986","unstructured":"Abe M, Hiraoka M, Takahashi M, Egawa S, Matsuda C, Onoyama Y, et al. Multi-institutional studies on hyperthermia using an 8-MHz radiofrequency capacitive heating device (Thermotron RF-8) in combination with radiation for cancer therapy. Cancer. 1986;58(8):1589\u201395.","journal-title":"Cancer"},{"issue":"12","key":"2585_CR23","doi-asserted-by":"publisher","first-page":"2898","DOI":"10.1002\/1097-0142(19841215)54:12<2898::AID-CNCR2820541214>3.0.CO;2-B","volume":"54","author":"M Hiraoka","year":"1984","unstructured":"Hiraoka M, Jo S, Dodo Y, Ono K, Takahashi M, Nishida H, et al. Clinical results of radiofrequency hyperthermia combined with radiation in the treatment of radioresistant cancers. Cancer. 1984;54(12):2898\u2013904.","journal-title":"Cancer"},{"issue":"3","key":"2585_CR24","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/S0033-8389(22)02139-X","volume":"27","author":"C Lee","year":"1989","unstructured":"Lee C, Song C, Rhee J, Levitt S. Clinical experience with thermotron RF-8 capacitive heating for bulky tumors: University of Minnesota experience. Radiol Clin North Am. 1989;27(3):543.","journal-title":"Radiol Clin North Am"},{"issue":"3","key":"2585_CR25","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.ijrobp.2017.04.017","volume":"100","author":"JA Vargo","year":"2018","unstructured":"Vargo JA, Ward MC, Caudell JJ, Riaz N, Dunlap NE, Isrow D, et al. A Multi-institutional Comparison of SBRT and IMRT for Definitive Reirradiation of Recurrent or Second Primary Head and Neck Cancer. Int J Radiat Oncol Biol Phys. 2018;100(3):595\u2013605.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"15","key":"2585_CR26","doi-asserted-by":"publisher","first-page":"3562","DOI":"10.1200\/JCO.2005.01.057","volume":"23","author":"MK Gibson","year":"2005","unstructured":"Gibson MK, Li Y, Murphy B, Hussain MH, DeConti RC, Ensley J, et al. Randomized phase III evaluation of cisplatin plus fluorouracil versus cisplatin plus paclitaxel in advanced head and neck cancer (E1395): an intergroup trial of the Eastern Cooperative Oncology Group. J Clin Oncol. 2005;23(15):3562\u20137.","journal-title":"J Clin Oncol"},{"issue":"3","key":"2585_CR27","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1080\/07357900701209061","volume":"25","author":"WE Samlowski","year":"2007","unstructured":"Samlowski WE, Moon J, Kuebler JP, Nichols CR, Gandara DR, Ozer H, et al. Evaluation of the combination of docetaxel\/carboplatin in patients with metastatic or recurrent squamous cell carcinoma of the head and neck (SCCHN): a Southwest Oncology Group Phase II study. Cancer Invest. 2007;25(3):182\u20138.","journal-title":"Cancer Invest"},{"issue":"17","key":"2585_CR28","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1056\/NEJMoa070956","volume":"357","author":"MR Posner","year":"2007","unstructured":"Posner MR, Hershock DM, Blajman CR, Mickiewicz E, Winquist E, Gorbounova V, et al. Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer. N Engl J Med. 2007;357(17):1705\u201315.","journal-title":"N Engl J Med"},{"issue":"3","key":"2585_CR29","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.clon.2004.09.013","volume":"17","author":"H Katori","year":"2005","unstructured":"Katori H, Tsukuda M. Comparison of induction chemotherapy with docetaxel, cisplatin, and 5-fluorouracil (TPF) followed by radiation vs concurrent chemoradiotherapy with TPF in patients with locally advanced squamous cell carcinoma of the head and neck. Clin Oncol. 2005;17(3):148\u201352.","journal-title":"Clin Oncol"},{"issue":"2","key":"2585_CR30","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1038\/sj.bjc.6601471","volume":"90","author":"H Katori","year":"2004","unstructured":"Katori H, Tsukuda M, Mochimatu I, Ishitoya J, Kawai S, Mikami Y, et al. Phase I trial of concurrent chemoradiotherapy with docetaxel, cisplatin and 5-fluorouracil (TPF) in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN). Br J Cancer. 2004;90(2):348\u201352.","journal-title":"Br J Cancer"},{"issue":"4","key":"2585_CR31","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1007\/s00280-009-1217-0","volume":"66","author":"M Tsukuda","year":"2010","unstructured":"Tsukuda M, Ishitoya J, Matsuda H, Horiuchi C, Taguchi T, Takahashi M, et al. Randomized controlled phase II comparison study of concurrent chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil versus CCRT with cisplatin, 5-fluorouracil, methotrexate and leucovorin in patients with locally advanced squamous cell carcinoma of the head and neck. Cancer Chemother Pharmacol. 2010;66(4):729\u201336.","journal-title":"Cancer Chemother Pharmacol"},{"issue":"5","key":"2585_CR32","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1002\/1097-0142(19810901)48:5<1116::AID-CNCR2820480512>3.0.CO;2-J","volume":"48","author":"J Overgaard","year":"1981","unstructured":"Overgaard J. Fractionated radiation and hyperthermia: experimental and clinical studies. Cancer. 1981;48(5):1116\u201323.","journal-title":"Cancer"},{"issue":"6","key":"2585_CR33","doi-asserted-by":"publisher","first-page":"483","DOI":"10.3109\/02656738709140422","volume":"3","author":"J Overgaard","year":"1987","unstructured":"Overgaard J, Overgaard M. Hyperthermia as an adjuvant to radiotherapy in the treatment of malignant melanoma. Int J Hyperthermia. 1987;3(6):483\u2013501.","journal-title":"Int J Hyperthermia"},{"key":"2585_CR34","unstructured":"Franken NA, Oei A, van Bree C, Barendsen GW, Rodermond H, Crezee J, et al. Radiosensitization with hyperthermia and chemotherapeutic agents: Effects on linear-quadratic parameters of radiation cell survival curves: INTECH Open Access Publisher; 2012."},{"issue":"11","key":"2585_CR35","doi-asserted-by":"publisher","first-page":"3755","DOI":"10.1158\/1078-0432.CCR-04-0054","volume":"10","author":"I Kuss","year":"2004","unstructured":"Kuss I, Hathaway B, Ferris RL, Gooding W, Whiteside TL. Decreased absolute counts of T lymphocyte subsets and their relation to disease in squamous cell carcinoma of the head and neck. Clin Cancer Res. 2004;10(11):3755\u201362.","journal-title":"Clin Cancer Res"},{"issue":"8","key":"2585_CR36","doi-asserted-by":"publisher","first-page":"5541","DOI":"10.4049\/jimmunol.175.8.5541","volume":"175","author":"S Dasgupta","year":"2005","unstructured":"Dasgupta S, Bhattacharya-Chatterjee M, O\u2019Malley BW, Chatterjee SK. Inhibition of NK cell activity through TGF-\u03b21 by down-regulation of NKG2D in a murine model of head and neck cancer. J Immunol. 2005;175(8):5541\u201350.","journal-title":"J Immunol"},{"issue":"6","key":"2585_CR37","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1159\/000081891","volume":"66","author":"RL Ferris","year":"2004","unstructured":"Ferris RL. Progress in head and neck cancer immunotherapy: can tolerance and immune suppression be reversed? ORL. 2004;66(6):332\u201340.","journal-title":"ORL"},{"issue":"8","key":"2585_CR38","doi-asserted-by":"publisher","first-page":"531","DOI":"10.3109\/02656736.2014.968640","volume":"30","author":"S Toraya-Brown","year":"2014","unstructured":"Toraya-Brown S, Fiering S. Local tumour hyperthermia as immunotherapy for metastatic cancer. Int J Hyperth. 2014;30(8):531\u20139.","journal-title":"Int J Hyperth"},{"issue":"6","key":"2585_CR39","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1016\/j.nano.2014.01.011","volume":"10","author":"S Toraya-Brown","year":"2014","unstructured":"Toraya-Brown S, Sheen MR, Zhang P, Chen L, Baird JR, Demidenko E, Turk MJ, Jack Hoopes P, Conejo-Garcia JR, Fiering S. Local hyperthermia treatment of tumors induces CD8+ T cell-mediated resistance against distal and secondary tumors. Nanomedicine: Nanotechnology, Biology and Medicine. 2014;10(6):1273\u201385. https:\/\/doi.org\/10.1016\/j.nano.2014.01.011.","journal-title":"Nanomedicine: Nanotechnology, Biology and Medicine"},{"issue":"7","key":"2585_CR40","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1001\/jamaoncol.2024.1143","volume":"10","author":"NF Saba","year":"2024","unstructured":"Saba NF, Wong SJ, Nasti T, McCook-Veal AA, McDonald MW, Stokes WA, et al. Intensity-modulated reirradiation therapy with nivolumab in recurrent or second primary head and neck squamous cell carcinoma: a nonrandomized controlled trial. JAMA Oncol. 2024;10(7):896\u2013904.","journal-title":"JAMA Oncol"},{"issue":"1","key":"2585_CR41","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.ijrobp.2011.11.054","volume":"84","author":"B Comet","year":"2012","unstructured":"Comet B, Kramar A, Faivre-Pierret M, Dewas S, Coche-Dequeant B, Degardin M, Lefebvre JL, Lacornerie T, Lartigau EF. Salvage stereotactic reirradiation with or without cetuximab for locally recurrent head-and-neck cancer: a feasibility study. International Journal of Radiation Oncology*Biology*Physics. 2012;84(1):203\u20139. https:\/\/doi.org\/10.1016\/j.ijrobp.2011.11.054.","journal-title":"International Journal of Radiation Oncology*Biology*Physics"},{"issue":"1","key":"2585_CR42","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1093\/jrr\/rrt098","volume":"55","author":"M Suzuki","year":"2013","unstructured":"Suzuki M, Kato I, Aihara T, Hiratsuka J, Yoshimura K, Niimi M, et al. Boron neutron capture therapy outcomes for advanced or recurrent head and neck cancer. J Radiat Res. 2013;55(1):146\u201353.","journal-title":"J Radiat Res"},{"issue":"4","key":"2585_CR43","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1016\/j.ijrobp.2016.07.037","volume":"96","author":"MW McDonald","year":"2016","unstructured":"McDonald MW, Zolali-Meybodi O, Lehnert SJ, Estabrook NC, Liu Y, Cohen-Gadol AA, et al. Reirradiation of recurrent and second primary head and neck cancer with proton therapy. Int J Radiat Oncol Biol Phys. 2016;96(4):808\u201319.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"2585_CR44","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.ijrobp.2019.07.021","volume":"105","author":"T Held","year":"2019","unstructured":"Held T, Windisch P, Akbaba S, Lang K, El Shafie R, Bernhardt D, et al. Carbon ion reirradiation for recurrent head and neck cancer: A single-institutional experience. Int J Radiat Oncol Biol Phys. 2019;105(4):803\u201311.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"2585_CR45","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.50607","volume":"6","author":"A Lee","year":"2023","unstructured":"Lee A, Woods R, Mahfouz A, Kitpanit S, Cartano O, Mohamed N, et al. Evaluation of proton therapy reirradiation for patients with recurrent head and neck squamous cell carcinoma. JAMA Netw Open. 2023;6(1): e2250607.","journal-title":"JAMA Netw Open"}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-025-02585-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13014-025-02585-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-025-02585-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T04:08:30Z","timestamp":1738987710000},"score":1,"resource":{"primary":{"URL":"https:\/\/ro-journal.biomedcentral.com\/articles\/10.1186\/s13014-025-02585-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,8]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2585"],"URL":"https:\/\/doi.org\/10.1186\/s13014-025-02585-z","relation":{},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,8]]},"assertion":[{"value":"25 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This phase II study was approved by the institutional review board of Shin Kong Wu Ho-Su Memorial Hospital (No. 20150205D).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Consent for publication was obtained.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"21"}}